SCPS (Scopus BioPharma) Book Value per Share: $-0.23 (As of Jun. 2023)


What is Scopus BioPharma Book Value per Share?

Scopus BioPharma SCPS Book Value per Share is $-0.23 as of Jun. 2023.

Scopus BioPharma's book value per share for the quarter that ended in Jun. 2023 was $-0.23.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Scopus BioPharma's current price is $0.0005. Its book value per share for the quarter that ended in Jun. 2023 was $-0.23. Hence, today's PB Ratio of Scopus BioPharma is .

Scopus BioPharma  (OTCPK:SCPS) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Scopus BioPharma Book Value per Share Related Terms

Scopus BioPharma Book Value per Share Historical Data

* Premium members only.

The historical data trend for Scopus BioPharma's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scopus BioPharma Book Value per Share Chart

Scopus BioPharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Book Value per Share
Get a 7-Day Free Trial 0.00 -0.01 -0.13 0.19 -0.31

Scopus BioPharma Quarterly Data
Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 -0.26 -0.31 -0.18 -0.23

SCPS vs AMPE, DRMA, SPRC: Book Value per Share Comparison

For the Biotechnology subindustry, Scopus BioPharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scopus BioPharma PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scopus BioPharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Scopus BioPharma's PB Ratio falls into.


Scopus BioPharma Book Value per Share Calculation

Scopus BioPharma's Book Value Per Share for the fiscal year that ended in Dec. 2022 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-6.56-0.00)/21.09
=-0.31

Scopus BioPharma's Book Value Per Share for the quarter that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-9.45-0.00)/42.08
=-0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of $-0.23 mean?
Scopus BioPharma (SCPS) has a Book Value per Share of $-0.23 as of Jun. 2023. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Scopus BioPharma and its competitors.
Is Scopus BioPharma's Book Value per Share too high?
Scopus BioPharma's current Book Value per Share is $-0.23.
How does Scopus BioPharma's Book Value per Share compare to AMPE and DRMA?
Scopus BioPharma's Book Value per Share of $-0.23 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Scopus BioPharma and its competitors. Scopus BioPharma's current Book Value per Share is $-0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scopus BioPharma stock overvalued right now?
Scopus BioPharma (SCPS) has a current Book Value per Share of $-0.23. The current Book Value per Share is $-0.23. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Scopus BioPharma (SCPS), the current Book Value per Share is $-0.23 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scopus BioPharma Business Description

Address 420 Lexington Avenue, Suite 300, New York, NY, USA, 10170
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.